Cargando…
Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis
The objective of our study was to perform an updated meta-analysis of placebo-controlled RCTs of Huperzine A (Hup A) on patients with Alzheimer's disease (AD) and vascular dementia (VD), in order to provide the basis and reference for clinical rational drug use. The primary outcome measures ass...
Autores principales: | Xing, Shu-huai, Zhu, Chun-xiao, Zhang, Rui, An, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930088/ https://www.ncbi.nlm.nih.gov/pubmed/24639880 http://dx.doi.org/10.1155/2014/363985 |
Ejemplares similares
-
Dissolving microneedles for transdermal delivery of huperzine A for the treatment of Alzheimer's disease
por: Yan, Qinying, et al.
Publicado: (2020) -
Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer’s Disease?
por: Qian, Zhong Ming, et al.
Publicado: (2014) -
Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
por: Friedli, María Jesús, et al.
Publicado: (2021) -
Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Yang, Guoyan, et al.
Publicado: (2013) -
Integration of System Biology Tools to Investigate Huperzine A as an Anti-Alzheimer Agent
por: Khanal, Pukar, et al.
Publicado: (2021)